Physician profile
Catherine Beecher
NPI 1164841151
$1,516.90
in general payments reported to CMS, 2019-2025
15 companies · $516 in 2025
The $516 reported for 2025 was more than what 81% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.94 · 2021: $217 · 2022: $417 · 2023: $121 · 2024: $223 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $288.39 | 2022-2025 | Solosec, Phexx, Phexxi |
| Alydia Health | $159.64 | 2021 | |
| Sumitomo Pharma America, INC. | $147.70 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $131.83 | 2021-2022 | |
| Exeltis, USA INC. | $104.76 | 2022-2025 | Slynd |
| Organon LLC | $92.87 | 2022-2024 | Nexplanon |
| Millicent US INC | $91.32 | 2025 | Femlyv, Intrarosa |
| Therapeuticsmd, INC. | $87.73 | 2021-2022 | |
| Astellas Pharma US INC | $84.58 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $83.98 | 2022 | |
| Mayne Pharma Commercial LLC | $77.28 | 2022-2025 | |
| Exact Sciences Corporation | $66.00 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $44.05 | 2020-2025 | |
| Myovant Sciences INC. | $40.09 | 2021-2022 | |
| Avion Pharmaceuticals | $16.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Beecher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.